JPRN-UMIN000023548招募中1 期
Hematopoietic stem cell transplantation from HLA fully mismatched family members for post-transplant relapse/rejection (phase I/II trial) - HLA fully mismatched hematopietic stem cell transplantation
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Cre > 2.0 mg/dl 2) EF < 40% 3) T-Bil > 2.0 mg/dl 4) AST and/or ALT > 200 U/L 5) SpO2 < 90% (room air) 6) PS (ECOG score) 3-4 Patients with data due to original disease are not excluded.
研究者
相似试验
未知
2 期
Hematopietic stem cell transplantation from HLA 2-3 antigen-mismatched family donor using reduced intensity conditioningJPRN-UMIN000023784Hyogo College of Medicine100
已完成
1 期
Allogeneic stem cell transplantation from HLA completely mismatched family donor for posttransplant relapsehematologic malignancies relapesd after allogeneic stem cell transplantationJPRN-UMIN000008117Hyogo College of Medicine20
招募中
2 期
HLA-haploidentical stem cell transplantation using a low dose ATG and steroidJPRN-UMIN000028845Hyogo College of Medicine100
已完成
1 期
HLA haploidentical stem cell transplantation using myeloablative regimen including ATGhematologic malignanciesJPRN-UMIN000004904Hyogo College of Medicine20
招募中
2 期
HLA haploidentical hematopoietic stem cell transplantation, Phase II trialhematologic malignancies, bone marrow failure syndrome, and other hematological disorders which requires hematopoietic stem cell transplantationJPRN-UMIN000027049Hyogo College of Medicine100